Dr. Dave Rogers joined adMare (previously known as CDRD) as its Intellectual Property Director in January, 2011. He has been involved in biotech patent law, particularly US patent law, since completion of his graduate research work in 1999. In 2000, he joined the San Francisco law firm of Flehr, Hohbach, Test, Albritton & Herbert LLP, which was later acquired by Dorsey and Whitney LLP. While working in San Francisco for Dorsey, he qualified as a patent agent before the US Patent and Trademark Office. In 2005, Dr. Rogers relocated to Dorsey’s Vancouver office, continuing to work closely with the San Francisco and Palo Alto offices to advise US and Canadian biotech clients on patent matters.
He has a background in biochemistry, chemistry, immunology, and neurobiology, and his IP experience includes patent drafting, patent prosecution, portfolio evaluation and development, patent analysis and opinion work (freedom to operate, invalidity, and non-infringement) and IP due diligence for licensing and financing. Dr. Rogers received a PhD from the Department of Neurology and Neurosurgery at McGill University in 1999, and a JD from the University of British Columbia in 2013.